By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Parasiticides2.34B24.73%
Vaccines1.96B20.69%
Dermatology1.75B18.53%
Anti-infectives1.04B10.94%
Pain and sedation840M8.87%
Other pharmaceuticals697M7.36%
Animal health diagnostics434M4.58%
Other non-pharmaceuticals263M2.78%
Contract manufacturing & human health116M1.23%
Other27M0.29%
View all
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States (US)5.1B53.84%
Other1.02B10.73%
Other Emerging Markets913M9.64%
Other Developed Markets641M6.77%
Brazil393M4.15%
Australia329M3.48%
United Kingdom325M3.43%
Canada290M3.06%
Germany236M2.49%
China227M2.40%
View all